YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Metabolic Phenotyping and Genotype of Dextromethorphan in Korean

덱스트로메토르판에 대한 한국인의 표현형 및 유전자형 분석

  • Published : 2002.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

The abuse of dextromethorphan has been prevalent for 15 years in Korea and its fatal cases were reported even though it has proved to be very safe. In this study, to investigate the safety and tolerance assessment of dextromethorphan, the metabolic phenotyping and genotype of dextromethorphan were studied. After a single 30 mg of dextromethorphan oral administration to 74 volunteers, concentration of dextromethorphan and its metabolites, dextrorphan, hydroxymorphinan and methoxymorphinan were measured in urine which collected during 8hrs after the drug administration. CYP2D6 phenotype was determined from the ratio of dextromethorphan to dextrorphan. GC/MS was used to quantify dextromethorphan and its metabolites. For genotyping, mutant alleles of the CYP2D6 gene were identified. 24 subjects (32.4％) were homozygous for CYP2D6＊10B, 29 subjects (39.2％) were heterozygous for this allele, while in 21 subjects (28.4％) no exon 1 mutation could be found. The frequency of CYP2D6＊10B-allele containing the 188C T mutation was 54％ of total subjects studied.

Keywords

References

  1. 정희선 : 생체시료에서 마약류의 검출, 도서출판 신일 상사, 서울 p. 47 (2000)
  2. Baselt, R. and Cravey, R. : Disposition of toxic drugs and chemicals in man. 'Dextromethorphan' 5th ed. Chemical Toxicology Institute, California p 242 (2000)
  3. Schadel, M. and Sellers, E. : Psychosis with Vicks formular 44D, Can Med Assoc. 147, 843 (1992)
  4. Darboe M. N, Keenan G, R Jr and Richards T. K. : The abuse of dextromethorphan-based cough syrup : a pilot study of the community of Waynesboro, Pennsylvania. Adolescence 31(123), 633 (1996)
  5. Darboe M. N. : Abuse of dextromethorphan-based cough syrup as a substitute for licit and illicitdrugs : a theoretical framework. Adolescence 31(121), 239 (1996)
  6. Brands B, Sproule B and Marshman J : Drug and drug abuse: A reference text. Ontario: Addiction Research foundation. 571 (1998)
  7. Yoo, Y. C., Lee, W. K., Chung, H. S., Lim, M. A., Kim, S. H., and Choi, H. K. : Blood concentration of dextromethorphan in fatal overdose. Annual Report of The National Institute of Scientific Investigation 20, 160 (1989)
  8. Yoo, Y. C., Chung, H. S., Kim, E. M., and Kim. M. D. : Fatal Zipeprol and dextromethorphan poisonings in Korea. J. Anal. Toxicol. 20, 155 (1996)
  9. Kopple C., Tneczer J. and Ibe, K. : Uinary metabolism of dextromethorphan in Man, Drug Research, 37, 1304 (1987)
  10. Barnhart, J. W. : The urinary excertion of dextromethophan and three metabolites in dogs and humans, Toxicology and applied pharmacology 55, 43 (1980)
  11. Vetticaden, S. J., Cabana, B. E., Prasad, V. K., Purich, E. D., Jonkman, J. H. J, de Zeeuw, R., Ball, L., Leeson, L. J. and Braun, R. L. : Phenotypic differences in dextromethorphan metabolism, Pharmaceutical Research 6(1), 13 (1989)
  12. Woodworth, J. R., Dennis S. R., Moore, L, Totenberg, K. S. : The polymorphic metabolism of dextromethorphan, J. Clin Pharmacol. 27, 139 (1987)
  13. Nagai, N., Takashi K, Fumiyo K, Mika I., Raito S., Yukihisa S., Hideo S., Akihiro O. and Hiroyasu O. : Pharmacokinetics and Polymorphic Oxidation of Dextromethorphan in a Japanese population. Biopharmaceutics & Drug disposition. 17, 421 (1996) https://doi.org/10.1002/(SICI)1099-081X(199607)17:5<421::AID-BDD421>3.0.CO;2-9
  14. Cai, W. M., Chen, B., Liu, Y. X. and Chu X. : Dextromethorphan metabolic phenotyping in a Chinese population, Chung Kuo Yao li hsueh Pao, 18, 441 (1997)
  15. Wang, S.-L., Huang, J.-D., Lai, M.-D., Liu, B.-H. and Lai, M. L. : Molecular basis of genetic variation in debrisoquine hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6. Clin. Phzrmacol. Ther. 53, 410 (1993)
  16. Nakamura K., Goto F., Ray W. A., McAllister C. B., Jacqz E., Wilkinson G. R. and Branch R. A. : Interethnic differences in genetic polymorphism of debrisoquine and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin. Pharmacol. Ther. 38, 402 (1985)
  17. Ishizaki, T., Eichelbaum, Y., Horai, K, Hashimoto, K., Chiba, K.and Dengler, H. J. : Evidence for polymorphic oxidation of sparteine in Japanese subjects. Br. J. Clin. Pharmac. 23, 482 (1987)
  18. Roh H. K, Dahl M.-L., Johansson I., Ingelman-Sundberg M., Cha Y. N. and Bertilsson L. : Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population. Pharmacogenetics 6, 441 (1996)
  19. Sohn D. R., Shin S. G., Park C. W., Kusaka M., Chiba K. and Ishizaki T. : Metoprolol oxidation polymorphism in a Korean population : Comparison with native Japanese and Chinese populations. Br. J. Clin. Pharmacol. 32, 504 (1991)
  20. Ramachander, G., Bapatla, K. R.and Emele, J. F.: Sex Differences in Plasma half-life of dextroephan in rats adtninistered dextromethorphan, J. Pharmacurtical Sciences 67(9), 1326 (1978)